Friar Lane, United Kingdom, July 08, 2016 --(PR.com
)-- According to a recently published report, the Infectious Disease Treatment Market is expected to grow by 8.2% CAGR during 2015-2022. The segmentation of global infectious disease treatment market is based onend user,application, product, technique and geography. The report on global infectious disease treatment market forecast 2015-2022 (by end user, application, product, technique and geography) provides detailed overview and predictive analysis of the market.
The escalating incidences of infectious diseases and the enhanced management & control of infectious diseases is driving the growth in the global infectious disease treatment market. HIV is the major health issue across the globe, according to WHO, in 2014 around 34 million people claimed it and around 1.6 million people died due to HIV globally. In spite of driving factors there are some factors which are restricting the growth of global infectious disease treatment market such as high healthcare cost, restricts usage of novel techniques and deferment authorizations of new diagnostic tests etc. The growing demand in emerging economies, increasing research and development initiatives and rising demand for personalized medicine are the key opportunities available in the global market. The rising prevalence of infectious diseases in Asia Pacific region is the major factor that is uplifting the growth and creating the opportunities in the global market for the forecasted period. However, the increasing investment opportunities from emerging countries are also creating developing platform in the global market.
Detailed study on this Report: http://www.briskinsights.com/report/infectious-disease-treatment-market